Boyu Hu
( out of 335 reviews )

Boyu Hu, MD

Languages spoken: English

  • Dr. Boyu Hu joined the Division of Hematology/Hematologic Malignancies in 2018. He specializes in treating patients with chronic lymphocytic leukemia and lymphoma. He completed his internal medicine residency at The Hospital of the University of Pennsylvania and then his fellowship training in Hematology/Oncology at the University of Texas MD Anderson Cancer Center. His research focuses on characterizing the genomic landscape within lymphoid malignancies to use not only as prognostic markers within the diseases but also as biomarkers to develop novel targeted therapies and therapy combinations to treat each condition. He is an active member within the Southwest Oncology Group and is the principle investigator on multiple phase I, II and III clinical trials.

    Specialties

    • Chronic Lymphocytic Leukemia
    • Hematology/BMT
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma

    Board Certification and Academic Information

    Academic Departments Internal Medicine - Primary

    Patient Rating

    4.9 /5
    ( out of 335 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    November 20, 2022

    Good

    October 25, 2022

    I was very impressed

    October 18, 2022

    Absolutely amazing service at Huntsman!

    See More Patient Comments

  • Dr. Boyu Hu joined the Division of Hematology/Hematologic Malignancies in 2018. He specializes in treating patients with chronic lymphocytic leukemia and lymphoma. He completed his internal medicine residency at The Hospital of the University of Pennsylvania and then his fellowship training in Hematology/Oncology at the University of Texas MD Anderson Cancer Center. His research focuses on characterizing the genomic landscape within lymphoid malignancies to use not only as prognostic markers within the diseases but also as biomarkers to develop novel targeted therapies and therapy combinations to treat each condition. He is an active member within the Southwest Oncology Group and is the principle investigator on multiple phase I, II and III clinical trials.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary

    Education history

    Fellowship Hematology/Oncology - University of Texas MD Anderson Cancer Center Fellow
    Internal Medicine - Hospital of the University of Pennsylvania Resident
    Internship Internal Medicine - Hospital of the University of Pennsylvania Intern
    Medicine - Case Western Reserve University School of Medicine M.D.
    Undergraduate Duke University B.S.